Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

B. Riley reiterates a Buy rating on Altimmune (ALT) with a $20 price target following the Q3 report. The company provided key pipeline updates ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

It allows providers to follow and coach and monitor patients who are going through a variety of different weight loss interventions, whether it’s the Allurion Balloon outside the United States GLP-1s.

These providers have put out ads for glucagon-like peptide 1 agonists, or GLP-1s, a class of drugs that are used to treat ...

Millions of people across the world benefit from weight loss drugs based on the hormone GLP-1. These drugs also improve ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today shared more data on the ...